IDiyas

For the Inventor, By the Inventor

Leucadia, CA, United States of America

John S Porter

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 288(Granted Patents)


Company Filing History:

goldMedal15 out of 576 
 
The Salk Institute for Biological Studies
 patents

Years Active: 1986-2004

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6747125 - Peptides intermediates for making GnRH antagonists (2004-06-08),
2. 5807986 - Methods of making and screening betide libraries (1998-09-15),
3. 5744450 - GnRH analogs (1998-04-28),
4. 5710249 - Amino acids and processes for making peptides using same (1998-01-20),
5. 5681928 - Betides and methods for screening peptides using same (1997-10-28),
6. 5580957 - GnRH analogs (1996-12-03),
7. 5565574 - Preparation of phenylalanine derivatives bearing a 1,2,4-triazole moiety (1996-10-15),
8. 5506207 - GNRH antagonists XIII (1996-04-09),
9. 5371070 - Bicyclic GnRH antagonists and a method for regulating the secretion of (1994-12-06),
10. 5352796 - Amino acids useful in making GnRH analogs (1994-10-04),
11. 5296468 - GnRH analogs (1994-03-22),
12. 5169935 - Method of making peptides (1992-12-08),
13. 5169932 - GnRH analogs (1992-12-08),
14. 4701499 - Synthesis of N-substituted peptide amides (1987-10-20),
15. 4569967 - Synthesis of N-substituted peptide amides (1986-02-11),

Title: Innovations of John S. Porter

Introduction

John S. Porter is a notable inventor based in Leucadia, California, with a remarkable portfolio of 15 patents. His work primarily focuses on the development of peptides and their applications in medical treatments.

Latest Patents

Among his latest patents, Porter has developed peptides that serve as intermediates for creating GnRH antagonists. These peptides, which include unnatural amino acids, play a crucial role in regulating the secretion of gonadotropins by the pituitary gland and inhibiting steroid release by the gonads. The administration of these GnRH antagonists can prevent ovulation in female mammals and may be utilized in treating steroid-dependent tumors. Additionally, he has created methods for making and screening betide libraries, which are compounds that mimic peptides and contain unique amino acid residues. This innovative approach allows for efficient screening of betides that can have various natural or unnatural amino acid substituents.

Career Highlights

Porter is affiliated with the Salk Institute for Biological Studies, where he contributes to groundbreaking research in biological sciences. His work has significantly advanced the understanding of peptide applications in reproductive health and cancer treatment.

Collaborations

Some of his notable coworkers include Jean E. Rivier and Carl A. Hoeger, who have collaborated with him on various research projects.

Conclusion

John S. Porter’s contributions to the field of peptide research and his innovative patents highlight his significant impact on medical science. His work continues to pave the way for advancements in treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…